COCHLEAR (COH) Shares

ABOUT COCHLEAR

Cochlear Limited is a Sydney-based medical device company that designs, manufactures and supplies across a high-value hearing aid portfolio including the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. The company has a history dating back to 1981, when it was first established with finance from the Australian government in order to commercialize these implants, which were first developed by Dr Graeme Clarke.

The company manufactures mainly in Sweden and Australia, as well as at a purpose-built facility at Macquarie University in Sydney.

In 2002 and 2003 Cochlear Limited was given the title of Australia’s most innovative company and named one of the world’s most innovative companies by Forbes in 2011.

OVERVIEW OF COCHLEAR

• Today, Cochlear Limited aims to support cochlear implantation becoming the standard of care for people with severe to profound hearing loss and to provide bone conduction implants for people with conductive hearing loss, mixed hearing loss and single-sided deafness. The company has provided more than 550,000 implant devices to people who benefit from one – or two – of the Company’s implantable solutions.

• The company invests more than US Dollar 180 million each year in R&D and currently participates in over 100 collaborative research programs worldwide. The global headquarters are on the campus of Macquarie University in Sydney, with regional offices in Asia Pacific, Europe and the Americas. The company has a deep geographical reach, selling in over 100 countries, with a direct presence in over 30 countries and a global workforce of over 4 000 employees.

• The company differentiates itself in the market through innovative, high-quality products and services, and customer information systems that deliver products and services to match customer preferences and needs. It works to be a dynamic, performance-focused organisation by creating a corporate culture and core values that attract and retain high-quality talent and adopts tools and processes for managing performance.

• The company creates shareholder value and meets stakeholder expectations through maximised sales revenues and an optimised sales revenue mix, maximised return from the effective management of working capital and other assets, and optimised return through a well-managed dividends policy.

VISION & VALUES OF COCHLEAR

• Cochlear Limited ethos is based on three core strategic values, namely innovation for a leading performance, delivering world-class design, and a lifetime commitment to its customers. The company strives to deliver groundbreaking capabilities, and improve those that already exist. As a result the company has come to lead the industry with the highest-performing, feature-packed cochlear implant systems.

• The company delivers world-class design throughout its product development, delivering an unrivalled listening experience through collaboration with a worldwide community of leading scientists in 70 countries, and global research and development conducted at its facilities in Australia, Belgium and the United States.

MARKET PERFORMANCE OF COCHLEAR

• Cochlear Limited trades on the Australian Securities Exchange (ASX), where investors can buy shares under the stock symbol -COH.

• Data from the company’s 2019 financial analysis shows a net profit of US Dollar 276.7 million, an increase of 13% on 2018. Reported net profit included a US Dollar 10.8 million net gain from the revaluation of innovation fund investments. Net profit excluding the revaluation was US Dollar 265.9 million, an increase of 7%. Earnings growth, combined with strong cash flow generation, supported second half dividends of US Dollar 1.75, with full year dividends increasing by 10 % to US Dollar 3.30, fully franked.

• The company’s strategy to retain market leadership and grow the hearing implant market has clear priorities that drive investment decisions and capital allocation. The company’s strong financial position enables the business to fund its growth activities while rewarding shareholders along the way with a growing dividend stream and a flourishing share price, making this a solid buy-in for investors who choose to purchase shares.

Buy COCHLEAR stocks / shares – A Step by Step Guide how to Buy / Purchase COCHLEAR Stocks or Shares online.

Before buying any stock or share one has to consider a few factors.

STEP 1: PROPER RESEARCH IS ESSENTIAL

Upon deciding you want to buy COCHLEAR Stocks / Shares, it is critical for the serious investor to do proper research into the said company. Its values should align with those of the investor’s current portfolio. An investor needs to familiarise himself with the basics and history of the company, as well as its leadership and performance in the market. Its company reports should also be scrutinized.

Consultation with a brokerage firm can also assist in determining whether investing in a specific company will complement the investor’s current portfolio. The investment “risk ladder”, which identifies asset classes based on their relative riskiness, is another useful tool when determining which company’s stock / share is the best to buy.

STEP 2: CALCULATE THE AMOUNT OF INVESTMENT IN COCHLEAR STOCKS / SHARES

It is important for an investor to monitor his total investment in stock in order to keep his portfolio aligned to his investment strategy. The overall value of his holdings will change with the fluctuation in stock prices, which can throw his portfolio off balance. To determine the amount to invest, multiply the number of shares of each stock by its current market price to determine the total investment in that specific stock. For example, if you own 100 shares of a US Dollar 5 stock, multiply 100 by US Dollar 5 to get US Dollar 500.

STEP 3: DECIDE ON THE STOCK / SHARE ORDER TYPE

Investors can choose from a market order, a limit order, a stop order (also referred to as a stop-loss order) or a buy/sell stop order. It is important to familiarise yourself with each type’s pros and cons before deciding which one will suit your current stock profile best. An investor should be guided in this choice by his investment objective.

STEP 4: OPEN A BROKERAGE ACCOUNT

A brokerage account – also known as taxable investment account – is similar to a retirement account, but more flexible. Where a retirement account has limitations on the amount of money that can be contributed annually, and restrictions on when funds can be withdrawn, a brokerage account is more flexible. The latter has no income or contribution limit and the investor can withdraw his money at any given time. This flexibility, together with its potential investment gains, makes a brokerage account more attractive to serious investors. Brokerage accounts are ideal for goals or savings that are further than five years away, but closer than retirement. It can also supplement an investor’s emergency savings.

STEP 5: COMMIT AND PURCHASE COCHLEAR STOCKS / SHARES

Lastly, commit to the stock. Pro Tip: Monitor the value of your stock to ensure you have a growing stock value and dividend pay-out.  Regularly check the share price online to ensure your investment delivers a positive return on investment. You are now a proud owner of COCHLEAR stocks / shares.

5 Questions to ask yourself before purchasing any stocks or shares.

1. Is it the best time to buy this stock / share?
2. Should I buy COCHLEAR stocks / shares in the current economic climate?
3. Can I afford to buy this stock / share?
4. What is the forecast of the stock / share growth?
5. What is the current price per earning ration on the stock / share?